ACAN Stock Overview
AmeriCann, Inc. designs, develops, leases, and operates cannabis cultivation, processing, and manufacturing facilities in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
AmeriCann, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.061 |
| 52 Week High | US$0.41 |
| 52 Week Low | US$0.051 |
| Beta | 1.48 |
| 1 Month Change | 1.67% |
| 3 Month Change | -24.69% |
| 1 Year Change | -73.48% |
| 3 Year Change | -94.94% |
| 5 Year Change | -95.23% |
| Change since IPO | -98.89% |
Recent News & Updates
Recent updates
Shareholder Returns
| ACAN | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | -0.6% | 1.0% |
| 1Y | -73.5% | 10.6% | 21.9% |
Price Volatility
| ACAN volatility | |
|---|---|
| ACAN Average Weekly Movement | 35.2% |
| Pharmaceuticals Industry Average Movement | 9.7% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: ACAN's share price has been volatile over the past 3 months.
Volatility Over Time: ACAN's weekly volatility has increased from 27% to 36% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 3 | Tim Keogh | www.americann.co |
AmeriCann, Inc. designs, develops, leases, and operates cannabis cultivation, processing, and manufacturing facilities in the United States. The company engages in the product manufacturing and greenhouse cultivation facilities for licensed cannabis business. Its flagship project is the Massachusetts Cannabis Center that is developed on a 52-acre parcel of land located in Freetown, southeastern Massachusetts.
AmeriCann, Inc. Fundamentals Summary
| ACAN fundamental statistics | |
|---|---|
| Market cap | US$1.49m |
| Earnings (TTM) | -US$289.50k |
| Revenue (TTM) | US$2.29m |
0.6x
P/S Ratio-5.1x
P/E RatioIs ACAN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ACAN income statement (TTM) | |
|---|---|
| Revenue | US$2.29m |
| Cost of Revenue | US$3.34k |
| Gross Profit | US$2.29m |
| Other Expenses | US$2.58m |
| Earnings | -US$289.50k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.012 |
| Gross Margin | 99.85% |
| Net Profit Margin | -12.63% |
| Debt/Equity Ratio | 91.8% |
How did ACAN perform over the long term?
See historical performance and comparison